pharma · Breast Cancer · Prostate Cancer · UTHR
United Therapeutics Europe
United Therapeutics Europe Ltd
United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertensi
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1000 Spring Street, Silver Spring, Maryland 20910, US
- Founded
- 1996
- Employees
- 1,443
- Programs
- 1032
- Drugs
- 612
- Patents
- 3720
Tranexamic Acid
Phase 3 · small molecule · Spinal Injuries
Tranexamic Acid for Spinal Injuries is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Internal code AAAQ6795
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- United Therapeutics Europe Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Spinal Injuries
- Status
- active
- Trials
- 1